CUSIP 578784100COMMAZEQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
142 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 4.57M | $189.22M | 0 | Held |
| 2 | Trv Gp IV, LLC | 4.47M | $185.36M | −1.60M | Reduced |
| 3 | Deep Track Capital, LP | 4.25M | $175.93M | +297.5K | Added |
| 4 | Arch Venture Management, LLC | 4.12M | $170.69M |
| 0 |
| Held |
| 5 | Janus Henderson Group PLC | 3.14M | $130.20M | +2.39M | Added |
| 6 | Blackrock, Inc. | 2.29M | $94.76M | +971.1K | Added |
| 7 | A16z Capital Management, L.L.C. | 1.70M | $70.52M | 0 | Held |
| 8 | Vanguard Group Inc | 1.70M | $70.31M | +362.1K | Added |
| 9 | Vr Adviser, LLC | 1.55M | $64.16M | +317.8K | Added |
| 10 | Alphabet Inc. | 1.39M | $57.53M | −1.02M | Reduced |
See every fund holding Maze Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders